Harbin Gloria Pharmaceuticals Co.,Ltd.’s Net Profit Rose 519.4% in First Three Quarters of 2023

Harbin Gloria Pharmaceuticals Co.,Ltd. (哈尔滨誉衡药业股份有限公司) (002437.SZ) reported a net profit of 231.1 million yuan in the first three quarters of 2023, up 519.4% year-on-year.

Meanwhile, the company posted 2.1 billion yuan in revenue, down 15% year-on-year.

At the end of the reporting period, it had 3.6 billion yuan in total assets and 1.7 billion yuan in total liabilities, with a liability-to-asset ratio of 47.8%.